Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

274 results about "Dose" patented technology

A dose is a measured quantity of a medicine, nutrient, or pathogen which is delivered as a unit. The greater the quantity delivered, the larger the dose. Doses are most commonly measured for compounds in medicine. The term is usually applied to the quantity of a drug or other agent administered for therapeutic purposes, but may be used to describe any case where a substance is introduced to the body. In nutrition, the term is usually applied to how much of a specific nutrient is in a person's diet or in a particular food, meal, or dietary supplement. For bacterial or viral agents, dose typically refers to the amount of the pathogen required to infect a host. For information on dosage of toxic substances, see Toxicology. For information on excessive intake of pharmaceutical agents, see Drug overdose.

Traditional Chinese medicine composition with effects of benefiting qi, nourishing blood, invigorating spleen and tonifying kidney and preparation method of traditional Chinese medicine composition

The invention discloses a traditional Chinese medicine composition with the effects of benefiting qi, nourishing blood, invigorating the spleen and tonifying the kidney and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: cistanche, ginseng, American ginseng, astragalus membranaceus, medlar, rhizoma polygonati, oyster peptide, angelica sinensis, radix rehmanniae preparata, donkey-hide gelatin, fructus amomi, pericarpium citri reticulatae, hawthorn, folium cortex eucommiae, radix puerariae, liquorice and the like. The preparation method comprises the following steps: respectively crushing the medicinal materials, dissolving the colla corii asini, mixing, adding water, granulating and the like. The composition can be prepared into various dosage forms such as granules, capsules, tablets, oral liquid and the like. Experiments show that the traditional Chinese medicine composition can effectively improve the symptoms of deficiency of qi and blood (increasing erythrocyte count and hemoglobin content), weakness of spleen and stomach (increasing body weight and improving pepsin activity) and kidney deficiency (reducing creatinine and urea nitrogen content and improving SOD activity), and acute toxicity experiments show that the toxicity is slightly reversible under high dosage, and the safety is good under therapeutic dosage. The traditional Chinese medicine composition has potential application value in the aspect of preparing medicines for benefiting qi, nourishing blood, invigorating spleen and tonifying kidney.
Owner:SHANDONG RENYITANG BIOTECHNOLOGY CO LTD

Systems, devices, and methods relating to medication dose guidance

Systems, devices and methods are provided for determining a medication dose for a patient or user. The dose determination can account for recent and / or historical analyte levels of the patient or user. The dose determination can also take into account other information about the patient or user, such as physiological information, dietary information, activity, and / or behavior. Many different dose determination embodiments are set forth, pertaining to a wide array of different aspects of the system or environment in which the embodiments can be implemented.
Owner:ABBOTT DIABETES CARE INC

Exosome surface modification by using NHS-PEG-NHS and application of exosome surface modification in targeted drug delivery

The invention belongs to the technical field of exosome modification, and particularly relates to an exosome modification method for connecting a target protein to the surface of an exosome by utilizing NHS-PEG-NHS to achieve a targeting or treatment effect, and application of the exosome modification method in targeted central nervous system demyelination disease treatment. In particular to a technology for modifying an exosome to enable the exosome to have targeting property and a preparation method of the exosome. NHS-PEG-NHS is used as a connecting substance, and protein, polypeptide and substances with primary amine groups on the surface can be connected to the surface of an exosome membrane. The modified exosome can load drugs and can be accurately delivered to tissues expressing specific proteins or polypeptides through oral administration, so that the bioavailability and the treatment effect of the drugs are remarkably improved. Taking the NG2 antibody modified cow milk exosome as an example, the NG2 antibody is connected to the surface of the cow milk exosome to target the central demyelination focus area, so that the effective therapeutic dose of the drug in the central focus area is achieved through oral delivery.
Owner:SHAANXI NORMAL UNIV

Preparation method and application of astragalus flavonoid extract with effect of treating systemic lupus erythematosus

The invention discloses a preparation method and application of an astragalus flavonoid extract with an effect of treating systemic lupus erythematosus, and belongs to the technical field of pharmaceutical preparations. The preparation method disclosed by the invention comprises the following steps: screening components for treating systemic lupus erythematosus target protein in astragalus membranaceus by adopting reverse network pharmacology; the preparation method comprises the following steps: preparing an astragalus flavonoid substance by adopting an ultrasonic-assisted deep eutectic solvent method, and extracting the astragalus flavonoid substance by using ethyl acetate to obtain an astragalus flavonoid ethyl acetate extract; preparing magnetic nanoparticles of which the surfaces are adsorbed with the target protein; and carrying out micromolecule fishing on the astragalus flavone ethyl acetate extract by adopting the magnetic nanoparticles, so as to obtain the astragalus flavone extract with the effect of treating systemic lupus erythematosus. The radix astragali flavonoid extract prepared by the invention has a higher curative effect on systemic lupus erythematosus, and has a better effect than the existing medicine under the same dosage.
Owner:SHANXI MEDICAL UNIV

Bacterial strain with effects of resisting allergy and improving immunity and application of bacterial strain

The invention belongs to the technical field of preparation of probiotics, and provides a bacterial strain with anti-allergic and immunity-improving effects and application of the bacterial strain. According to the method, a three-layer physical self-assembly structure is adopted, and polysaccharide-polyphenol layer-by-layer self-assembly coating treatment, lipid insertion layer treatment and calcium ion crosslinking protection coating treatment are sequentially carried out. And mannan oligosaccharide MOS and / or galactooligosaccharide GOS are / is mixed in the chitosan layer in a ratio of 0.05-0.15% w / v, and the surface sugar ligand density reaches 4-8 [mu] g per 10 CFU. The coating is constructed under the condition that the pH value is 5.4-5.8; the thickness of the lipid layer is 20-80 nm when the pH value is 5.6-6.2; the cross-linked layer is treated at the pH of 6.0-6.5, so that the gastric acid environment is stable for 2 hours, and the gastric acid is controllably released in intestinal juice for 2-4 hours. The prepared strain has the total thickness of 220-900 nm, the outermost layer coverage rate is larger than or equal to 85%, the gastric juice survival rate is remarkably improved, the strain can be prepared into an oral preparation to be used for preventing and relieving allergic diseases, the viable count of each dose is 1 * 10 <-1 > * 10 <-1 > CFU, and the process is mild and suitable for industrial production.
Owner:SHANGHAI HELPLIFES TECH CO LTD

Method for evaluating endotoxin adsorption performance of hemoperfusion device

The invention provides a method for evaluating the endotoxin adsorption performance of a hemoperfusion device, which comprises a construction method of an endotoxemia rabbit model and comprises the following steps: injecting a bacterial liquid containing bacteria into a rabbit once to generate endotoxin in the rabbit body, the type of the bacteria is escherichia coli, the injection dosage of the bacterial liquid is 0.1-2mL, the OD600 value of the bacterial liquid is 1.3-1.7, and the endotoxin is generated in the rabbit body. And injecting the bacterial liquid for at least 3h to obtain the endotoxemia rabbit model. The endotoxemia rabbit model is used as an animal model for evaluating the endotoxin adsorption performance of the hemoperfusion device, the influence of factors of an animal body on the endotoxin concentration can be eliminated, and the endotoxin adsorption performance of the hemoperfusion device can be accurately and objectively evaluated.
Owner:JAFRON BIOMEDICAL

Method and system for analyzing bacterium-drug interaction panoramic dynamic mechanism by using causal enlightenment hypergraph neural network, and electronic equipment

The invention discloses a method and system for analyzing a bacterium-drug interaction panoramic dynamic mechanism by using a causal enlightenment hypergraph neural network, and electronic equipment, and belongs to the technical field of artificial intelligence and biomedical informatics. The method comprises the following steps: constructing a disease / syndrome / disease-bacterium / microorganism / metabolite-prescription / drug / component interlocking hypergraph; analyzing a bacteria-drug interaction dynamic mechanism based on a dynamic hypergraph network algorithm; optimizing the hypergraph neural network based on the prescription compatibility rule and the traditional Chinese medicine dosage; and predicting the microbial marker based on the causal enlightenment hypergraph neural network. According to the method, a multi-entity high-order relation is captured through an interlocking hypergraph structure, a time sliding window and an attenuation mechanism are introduced to analyze dynamic evolution, the traditional Chinese medicine dosage is used as an attention priori optimization network, and causal reasoning is achieved through alternate optimization of an intervention discovery and response prediction module. In a public data set test, the performance evaluation index is obviously superior to that in the prior art, and the problem of analyzing the panoramic dynamic mechanism of the bacterium-drug interaction is effectively solved.
Owner:HUNAN ACAD OF CHINESE MEDICINE

Preparation method for constructing SHBG-reduced polycystic ovarian syndrome rat model based on ruminococcus lividus

The invention discloses a method for constructing a polycystic ovarian syndrome (PCOS) rat model with reduced sex hormone binding globulin (SHBG) on the basis of ruminococcus aureus with the preservation number of ATCC29149, and belongs to the technical field of animal models. According to the present invention, the bacterial strain is subjected to anaerobic culture to prepare the bacterial liquid, the dosage is 0.2-1 mL / 100 g, the intragastric administration frequency is one time per day to two times per week, and the time lasts for 4-8 weeks, such that the SHBG synthesis of the rat liver is induced to decrease, and the PCOS pathological characteristics such as testosterone level increase, estrus cycle disorder, ovarian polycystic change, insulin resistance and the like are initiated; the problem that a traditional hormone induction method does not conform to the physiological status is solved, the modeling period of a high-fat diet induction method is shortened, and an efficient experimental tool is provided for PCOS mechanism research and drug development.
Owner:SHENGJING HOSPITAL OF CHINA MEDICAL UNIVERSITY

Method and device for predicting content change of medicine in living body

The invention discloses a method and a device for predicting the content change of a drug in a living body. According to the method, a kinetic reaction system of a test substance is constructed in vitro by using the microparticles, so that the test substance fully reacts in the microparticles, and reaction conditions for carrying out an in-vitro kinetic experiment by using the microparticles are determined. Through the constructed microsome reaction system, the metabolic rate of a test substance in the liver and / or small intestine of an organism is calculated, a computer is utilized to compile metabolic kinetic parameters into a calculus equation, then the calculus equation is solved, and finally the kinetic process of the test substance is obtained. Therefore, the defect that toxicity experiments are carried out by using in-vitro biological tissue bodies is overcome. On the premise that animal experiments do not need to be carried out, the toxicity characteristics of the medicine in the mouse liver can be analyzed, and the dosage generating hepatotoxicity can be predicted.
Owner:INST OF QUALITY STANDARD & TESTING TECH FOR AGRO PROD OF CAAS

Point of care testing system for antithrombin iii

Compounds and compositions for determining the level of antithrombin (ATIII) in a sample are described along with a system for determining the level of ATIII in a point-of-care setting. Methods of forming the compounds and compositions are also described. Methods of using the compounds and compositions to quantify the level of ATIII in a subject are further described. A system and apparatus are provided that determine the level of ATIII in a point-of-care setting in an efficient manner to facilitate determining a dosage or heparin or ATIII to administer to a patient.
Owner:UNIV OF FLORIDA RESEARCH FOUNDATION INC

Residual CARB estimation for bolus calculation

A processor-implemented method comprises obtaining measured glucose values of a person, fitting a physiological model to a portion of the measured glucose values within a time window after a start of a meal to determine meal-specific values of parameters of the physiological model that characterizes the person's glycemic response to the meal, estimating an amount of residual glucose or residual carbohydrate of the meal that would not be counteracted by insulin already delivered to the person using the physiological model and the meal-specific values of the parameters of the physiological model, and determining a dose of a correction bolus to be delivered to the person based on the amount of residual glucose or residual carbohydrate of the meal.
Owner:MEDTRONIC MINIMED INC

Smart nutrition dosing

A method of dosing food and nutrients for an individual patient, by collecting data from the individual patient including food and nutrients to be taken by the patient, analyzing the data in view of dosing criteria established based on outside data, and determining a dose for each food and nutrient taken by the individual patient. A logic engine for dosing food and nutrients, including an algorithm stored on non-transitory computer readable media for collecting outside data to establish criteria for dosing food and nutrients to an individual patient and patient data and storing outside data and patient data in a database, analyzing the individual patient data in view of criteria established from the outside data, and determining a dose for each food and nutrient to be taken.
Owner:OPTIMDOSING LLC

Computer system for managing dosage timing of tacrolimus

PendingGB2630386ADrug and medicationsData processing systemBaseline concentration
A data processing system configured to provide to a user, an indication of an optimal timing for regular administration of Tacrolimus to a patient and provide to the user, an indication of an acceptable range around the optimal timing at which a dose of Tacrolimus may be taken. The Tacrolimus levels are predicted based upon a previous measurement of the Tacrolimus concentration in serum of the patient and based upon the current dosage and body weight of the patient. This predication is then used, along with one or more earlier measurement, to establish a baseline concentration value against which deviations can be measured. If a new measurement indicates a significant deviation from the baseline concentration value, where this deviation is above a threshold, the acceptable range is reduced, and an alert is transmitted. In this way, greater timing discipline is enforced if large deviations from the baseline are measured. The prediction may use an exponential decay function starting from an initial dosage level of Tacrolimus.
Owner:HEALTH-AI HLDG LTD

Method and device for performing rat contamination experiment blood biochemical and blood routine index generative prediction on chemicals based on multi-modal fusion and GANs model

ActiveCN119274662Aimprove welfareAuxiliary managementBiostatisticsBiological modelsAnimal welfareData source
The invention discloses a method for performing rat contamination experiment blood biochemical and blood routine index generative prediction on a chemical substance based on multi-modal fusion and a GANs model. The method comprises the following steps: S1, obtaining an SMILES formula of the chemical substance to be predicted; s2, acquiring data of three modes of the chemical substance, wherein the data comprises a molecular mechanism, biological activity and batch key molecular docking activity; s3, combining the contamination dose and contamination time of the three modal data, and inputting the combined data into a pre-trained alternative rat experiment prediction model; s4, an output result of the replacement rat experiment prediction model is generative prediction values of 25 indexes of blood biochemistry and blood routine under the set contamination dose and set contamination time of the data source chemicals. According to the method, the prediction precision and efficiency are greatly improved, the toxicity identification and management of novel chemicals can be effectively assisted, the time and energy of experimenters are effectively saved, animal resources are saved, and animal welfare is improved.
Owner:NANJING MEDICAL UNIV

Tailored nutritional supplements for athletic performance

A personalized supplement formulation system integrates biological data, structured qualitative feedback, and machine learning algorithms to generate individualized nutritional protocols. The system receives biological inputs such as genetic single nucleotide polymorphism (SNP) data, blood biomarkers (e.g., ferritin, vitamin D, B12), lipid profiles, and urinary metabolites. A digital user profile is created by organizing these inputs and calculating derived indices relevant to supplementation. Structured qualitative feedback, including dietary restrictions, perceived wellness, and training goals, is normalized and processed alongside the biological data. A trained machine learning engine analyzes combined inputs to output a tailored supplement formulation specifying ingredient selection, dosage, delivery format, and timing. Instructions are transmitted to a manufacturing system capable of producing the custom formulation. The system supports periodic re-evaluation and iteration based on new biological samples or user-reported feedback, enabling dynamic personalization over time and improving efficacy, compliance, and outcome tracking in athletic and wellness domains.
Owner:OPTIGENIX

Method for treating disease by levoketoconazole

ActiveJP2025026838AOrganic active ingredientsMetabolism disorderDiseaseAbnormal renal function
To provide a pharmaceutical composition for treating hypercortisolism in a subject of Cushing's syndrome.SOLUTION: A pharmaceutical composition contains levoketoconazole or a pharmaceutically acceptable salt thereof, and is administered to a subject in need thereof in a therapeutically effective amount. The pharmaceutical composition is administered with a therapeutically effective amount of metformin or a pharmaceutically acceptable salt thereof. The subject also has type 2 diabetes and has had previous surgery or radiation to treat Cushing's syndrome. The therapeutically effective amount of the pharmaceutical composition is determined via a titration scheme including dose escalation of the pharmaceutical composition. When the subject experiences a dose limitation event, metformin or a pharmaceutically acceptable salt thereof is administered at a dose that is less than the therapeutically effective amount. The dose limitation event is reduction of a fasting blood glucose level, an abnormal renal function, a low vitamin B-12 level or any combination thereof.SELECTED DRAWING: None
Owner:STRONGBRIDGE DUBLIN LTD

Acupoint sticking traditional Chinese medicine composition with effect of treating irritable bowel syndrome, acupoint patch and preparation method and application thereof

PendingCN122624615ADiseaseEfficacy
The application discloses a point application traditional Chinese medicine composition with an effect of treating irritable bowel syndrome, a point application plaster and a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines. The application provides a point application traditional Chinese medicine composition and a point application plaster. The traditional Chinese medicine composition comprises the following components: psoralea, radix codonopsis, dried zedoary, fried atractylodes, mace, schisandra chinensis and evodia. The composition is prepared according to the principle of less medicine and special function and treatment of disease and seeking the origin. The core tonifying medicine, psoralea, dried zedoary and radix codonopsis, has a prominent dosage proportion and remarkable effects of warming the spleen and kidney yang and invigorating the spleen and replenishing qi. The application finds through clinical research that the clinical total effective rate of the test group is 76.7%, the curative effect is accurate and better than that of a placebo, the IBS-SSS score, the TCM syndrome score and the stool character score of IBS patients can be reduced, the symptoms of the patients are improved, and the composition can effectively treat IBS.
Owner:DONGFANG HOSPITAL BEIJING UNIV OF CHINESE MEDICINE

Composition derived from okra for enhancing stamina, process for its preparation and use thereof

PendingCN123036101AAnimal scienceNutrition
The present invention relates to a palatable, free-flowing powdered composition derived from Abelmoschus esculentus for enhancing endurance. The composition comprises polysaccharides (5-50%) including rhamnogalacturonans and arabinogalactans; flavonoid glycosides (2-10%) including quercetin 3-O-gentiobioside and isoquercitrin (Okraenduroside); and total carbohydrates (30-70%), along with optional excipients for stability and bioavailability. The composition, when administered to a subject in an appropriate dose, improves running endurance, enhances swimming endurance, improves rate of perceived exertion (RPE), ameliorates severity of fatigue, improves fatigue score, increases peak power, and enhances endurance and muscle performance. The invention also discloses a method of preparation involving aqueous-alcoholic extraction, concentration, and purification to obtain a water-soluble powder. The composition can be formulated into capsules, tablets, powders, and beverages and administered orally at a dose of 100-2000 mg / day. Animal and human studies confirm the efficacy of the composition for enhancing endurance, making it suitable for the nutraceutical, sports nutrition, and pharmaceutical industries.
Owner:ARJUNA NATURAL PTE LTD

Prediction method and device for optimal ratio of arginine to lysine in daily ration of lactating sow

The invention relates to the technical field of information, and discloses a method for predicting the optimal ratio of arginine to lysine in daily ration of lactating sows, and the method comprises the following steps: 1, obtaining historical production data and feed formula data; 2, performing data preprocessing on the historical production data and the feed formula data to obtain historical feature vectors and formula sample data; 3, selecting a preset model with the best performance as a prediction model according to the performance indexes; 4, inputting the to-be-detected feature vector and the crude protein content into the prediction model, and outputting a proportion prediction value of arginine and lysine by the prediction model; 5, performing a field dose response test and acquiring field data; and step 6, inputting the field data into the prediction model, detecting whether data drift occurs in the field data, performing incremental learning when no significant drift occurs in the field data, and performing full-amount learning when significant drift occurs in the field data. The invention further discloses a device for predicting the optimal arginine and lysine ratio of the daily ration of the lactating sows.
Owner:ANIMAL SCI RES INST GUANGDONG ACADEMY OF AGRI SCI +1

Methods and kits for treating fever in children with a combination of ibuprofen and acetaminophen

Provide various dosage forms, including dosage methods and regimens for treating fever in children, as well as formulations and kits. One dosage regimen or method for treating a child with fever includes administering a dose to a child, the dose comprising a) a predetermined amount of ibuprofen, and b) a predetermined amount of acetaminophen, the predetermined amount being determined by the child's weight. Various carriers, such as liquid, solid, and semi-solid, can be used in the formulation. Provide a dosage chart that includes the amount of ibuprofen and acetaminophen compound in the formulation.
Owner:ゾンフリロマーク ロバート

A nutritional care intervention system and method for tumor radiotherapy and chemotherapy patients

The present invention discloses a nutritional care intervention system and method for tumor radiotherapy and chemotherapy patients, belonging to the field of nutritional care intervention. The present invention obtains patient data, obtains patient basic information, treatment plans and constructs a dynamic knowledge base, constructs a nutritional element intake gap model, imports the recommended daily intake and actual intake of nutritional elements of the patient into the nutritional element intake gap model to evaluate the nutritional gap, constructs a drug metabolism and organ tolerance model, imports radiotherapy and chemotherapy drug parameters into the drug metabolism and organ tolerance model to evaluate the drug metabolism situation and organ tolerance dose, constructs a nutritional risk assessment model, and imports the relative nutritional element gap vector, drug metabolism amount, organ tolerance dose, and patient tumor stage into the nutritional risk assessment model to evaluate the patient's nutritional risk. The present invention comprehensively evaluates the patient's nutritional risk based on the patient's nutritional intake situation, drug metabolism process and organ tolerance, and conducts nutritional care intervention on the patient.
Owner:SICHUAN CANCER HOSPITAL

Protocol for treatment of lupus nephritis

To provide a method for treating a proteinuric kidney disease.SOLUTION: There is provided a method comprising administering a predetermined daily dosage of effective amounts of voclosporin over a projected treatment period of at least 24 weeks. The method further comprises: (a) assessing an estimated Glomerular Filtration Rate (eGFR) of a subject at at least a first time point and a second time point on different days within the treatment period; and (b) (i) when the eGFR of the subject decreases by more than a target % to below a predetermined value between the first and second time points, reducing the daily dosage by units of 7.9 mg BID or discontinuing the administration of voclosporin to the subject; (ii) when the eGFR of the subject decreases by less than the target % between the first and second time points, continuing to administer the same predetermined daily dosage of voclosporin to the subject.SELECTED DRAWING: Figure 1
Owner:AURINIA PHARMACEUTICALS INC

Artificial intelligence-based dynamic decision system and method for critical patient nutrition

PendingCN123033662ANutritionDynamic monitoring
The application is a critical patient nutrition full-process dynamic decision system and method based on artificial intelligence, comprising: multi-source heterogeneous data acquisition and integration, hierarchical dynamic nutrition risk assessment (three-level architecture of preliminary screening-diagnosis-dynamic re-evaluation), evidence-based nutrition starting decision, dynamic monitoring and dose adjustment based on deep reinforcement learning, five-step nutrition intervention two-way intelligent switching, and graded early warning and report output. Each step operation is executed by a multi-model fusion artificial intelligence decision engine including a four-layer architecture. The scheme can convert critical nutrition guidelines into standardized calculation rules that can be automatically executed, realizing real-time dynamic identification of nutrition risk, standardized starting decision, automatic warning of re-feeding syndrome, and full-process closed-loop dynamic management. It is expected to improve the individualization and precision of critical patient nutrition support.
Owner:THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV

Methods and compositions using dichrostachys glomerata to reduce anxiety, food cravings and stress and improve mood, physical health, mental health, energy and happiness in a mammal

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for improving mood in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
Owner:KOTHARI SHIL

Intravenous solution stabilizer

PCT designated stageWO2026110106A1Immunoglobulin superfamilyPharmaceutical delivery mechanismProtein solutionIntravenous solutions
The present disclosure provides a method of administering a low dose soluble protein to a subject in need thereof, wherein the method comprises (a) adding an intravenous solution stabilizer ("IVSS") to an isotonic aqueous solution in a container to form a pretreated container, (b) adding an amount from a protein stock solution to the pretreated container of step (a) to form a low dose protein solution, and (c) administering the low dose protein solution of step (b) to the subject. Optionally, the dose of the soluble protein to be administered to the subject is an ultra-low dose protein, wherein the low dose protein solution undergoes a further dilution step. In particular, the method of administering an ultra-low dose soluble protein comprises: (a) adding an IVSS to an isotonic aqueous solution in a first container to form a first pretreated container, (b) adding an amount from the protein stock solution to the first pretreated container to form a low dose protein solution; (c) adding an IVSS to an isotonic aqueous solution in a second container to form a second pretreated container; and (d) adding an amount of the low dose protein solution in step (b) to the second pretreated container of step (c) to form an ultra-low dose protein solution, and (e) administering the low dose protein solution of step (b) to an individual in need thereof.
Owner:IMMUNOCORE LTD

Application of aromatic hydrocarbon receptor stimulant in preparation of medicine for treating diarrhea of weaned piglets and / or inhibiting inflammation

The invention discloses application of an aromatic hydrocarbon receptor stimulant in preparation of a medicine for treating diarrhea of weaned piglets and / or inhibiting inflammation, and belongs to the field of biological medicine. According to the present invention, with the PAS-B structural domain of the AHR as the target, the virtual screening technology, the target verification test and the weaned piglet diarrhea pharmacodynamic evaluation test are performed to determine the arctigenin as the AHR strong agonist and the anti-inflammatory drug, and the arctigenin has the good treatment effect on the weaned piglet diarrhea. Experimental results show that 10 mg / kg of arctigenin can significantly relieve diarrhea and hemafecia symptoms of weaned piglets, reduce the content of inflammatory factors in serum and intestinal tissues and improve the intestinal structure of weaned piglets, has no significant cytotoxicity, hepatorenal toxicity and intestinal epithelial cell growth inhibition effect, and can be used for preparing a feed additive for weaned piglets. The compound can be used for preparing medicines for treating diarrhea of weaned piglets. The invention provides a new raw material medicine for treating diarrhea of weaned piglets, and has great economic value and wide application prospect.
Owner:HUAZHONG AGRI UNIV

A medical data driven-based hypothyroid individualized dose prediction method, system, device and storage medium

PendingCN122245605AGood prediction accuracySolve problems that have not been quantifiedMedical data miningEnsemble learningEtiology# previous doses
This invention relates to the field of medical data-driven dose prediction technology, and discloses a method, system, device, and storage medium for individualized dose prediction of hypothyroidism based on medical data. The method includes: constructing a standardized feature vector based on the child's weight, age in days, corrected age in months, current L-T4 dose, TSH value, FT4 value, previous TSH value, TSH rate of change, feeding method, month of consultation, etiology of hypothyroidism, comorbidity status, previous dose adjustment magnitude, and age at which TSH first reached target levels; extracting TSH dynamic trajectory features from the child's TSH time-series data from previous follow-ups; obtaining a basic recommended dose using a gradient boosting decision tree model constructed with counterfactual filtering training data; and correcting the basic recommended dose to obtain an individualized recommended dose. This method improves the prediction accuracy of the gradient boosting decision tree model and allows the individualized recommended dose to simultaneously take into account multiple clinical confounding factors.
Owner:SHENZHEN MATERNITY & CHILD HEALTHCARE HOSPITAL

Methods of suppressing delivery of exosomes to liver and spleen

The instant application describes improved methods and compositions for the systemic delivery of therapeutic exosomes to a subject in need thereof. In certain embodiments, the current invention reduces the amount of exosomes delivered to liver, spleen and combinations thereof to allow greater distribution to other areas of the body such as, but not limited to, the brain, pancreas, lung, kidney, muscle. In certain embodiments, the methods involve the injection of one or multiple doses of non-therapeutic exosomes prior to the injection of a suitable therapeutic dose of exosomes with a therapeutic payload. Also included are methods to improve immune clearance of exosomes in subjects by inhibiting phagocytosis.
Owner:LONZA SALES AG

Micro-enema preparation and quantitative evaluation method for improving rectal magnetic resonance image quality

The invention provides a micro-enema preparation and quantitative evaluation method for improving the quality of a rectum magnetic resonance image, and the method comprises the steps: S2, carrying out a glycerine enema micro-enema operation, squeezing glycerine enema into the rectum, maintaining the operation for a preset time, and recording the defecation frequency and the last defecation character; s3, selecting the dosage of the microenema enema, carrying out grouped experiments by setting a plurality of doses, recording related scores, and selecting the dosage of the enema enema meeting clinical requirements; s4, selecting an on-machine time window before magnetic resonance examination after microenema, performing rectum magnetic resonance examination at a plurality of time nodes after defecation through grouping experiments, observing related scores, and selecting an on-machine time window with a good intestinal tract preparation effect; and S5, carrying out micro-enema adverse reaction evaluation, evaluating a plurality of grades of the subject, calculating an adverse reaction score according to a weighting formula, carrying out clinical decision making, and if the adverse reaction score is lower than a threshold value, terminating the operation and carrying out further processing.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Application of nutritional composition containing alpha-hydroxyisocaproic acid in weight management and blood fat improvement

The invention discloses application of a nutritional composition containing alpha-hydroxyisocaproic acid in weight management and blood fat improvement, and belongs to the fields of biological medicine manufacturing, biological medicine application and functional food development. The nutritional composition comprises alpha-hydroxyisocaproic acid and at least one second functional nutritional component, and the second functional nutritional component is preferably selected from one or more of the following components: 1) one or more of tea polyphenol and capsaicin; 2) one or more of beta-glucan, inulin and resistant dextrin; 3) one or more of medium chain triglyceride and sn-1, 3 diglyceride; under the condition of the same intake cycle and dosage, the nutritional composition can significantly improve the weight management effect and reduce related indexes of blood fat through a multi-way synergistic effect, and is combined with GLP-1 drugs or sequentially applied to weight management so as to reduce the risk of weight rise after drug withdrawal.
Owner:DALIAN POLYTECHNIC UNIVERSITY